Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors

Circulation - United States
doi 10.1161/01.cir.100.7.700
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Exercise Training in HIV-1-Infected Individuals With Dyslipidemia and Lipodystrophy

Medicine and Science in Sports and Exercise
Sports MedicinePhysical TherapySports ScienceOrthopedicsSports TherapyRehabilitation
2006English

Renal Function in HIV-infected Children and Adolescents Treated With Tenofovir Disoproxil Fumarate and Protease Inhibitors

BMC Infectious Diseases
Infectious Diseases
2012English

Proteinuria Is Associated With Neurocognitive Impairment in Antiretroviral Therapy Treated HIV-Infected Individuals

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2014English

Hemostasis in HIV Infected Individuals

Journal of Medical Science And clinical Research
2018English

HIV and cART-Associated Dyslipidemia Among HIV-Infected Children

Journal of Clinical Medicine
2019English

HIV Protease Inhibitors and Obesity

Current Opinion in Endocrinology, Diabetes and Obesity
Internal MedicineNutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2010English

Endobronchial Lesions in HIV-infected Individuals

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1994English

Oral Candidiasis in HIV+ Patients Under Treatment With Protease Inhibitors

Brazilian Oral Research
2008English

Atherogenic Dyslipidemia in Diabetic Nephropathy: Lipoprotein (A), Lipid Ratios and Atherogenic Index

International Journal of Research in Medical Sciences
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy